Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: NEOVAXSYN INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2024-07-01 to 2027-06-30
Current total value of award: $2000000
Description: NANOVACCINE FOR ELICITING BNABS AGAINST HIV-1